121 related articles for article (PubMed ID: 4196901)
1. Carbon-13 nuclear magnetic resonance studies on thyrotropin-releasing factor and related peptides.
Deslauriers R; Garrigou-Lagrange C; Bellocq AM; Smith UC
FEBS Lett; 1973 Apr; 31(1):59-66. PubMed ID: 4196901
[No Abstract] [Full Text] [Related]
2. Carbon-13 nuclear magnetic resonance studies of structure and function in thyrotropin-releasing factor. Determination of the tautomeric form of histidine and relationship to biology activity.
Deslauriers R; McGregor WH; Sarantakis D; Smith IC
Biochemistry; 1974 Aug; 13(17):3443-8. PubMed ID: 4211032
[No Abstract] [Full Text] [Related]
3. Carbon-13 NMR studies of peptide hormones and their components.
Smith IC; Deslauriers R; Saitô H; Walter R; Garrigou-Lagrange C; McGregor H; Sarantakis D
Ann N Y Acad Sci; 1973 Dec; 222():597-627. PubMed ID: 4361873
[No Abstract] [Full Text] [Related]
4. 13C nuclear magnetic resonance studies of the conformation of the X-pro bond in the oligopeptide hormones, thyrotropin-releasing hormone, luteinizing hormone-releasing factor, angiotensin and melanocyte-stimulating hormone release-inhibiting factor.
Deslauriers R; Walter R; Smith IC
Biochem Biophys Res Commun; 1973 Jul; 53(1):244-50. PubMed ID: 4354931
[No Abstract] [Full Text] [Related]
5. 1H nuclear magnetic resonance studies of thyrotropin releasing factor (TRF).
Feeney J; Bedford GR; Wessels PL
FEBS Lett; 1974 Jun; 42(3):347-51. PubMed ID: 4369451
[No Abstract] [Full Text] [Related]
6. 13C-nuclear magnetic resonance study of [85% 13C-enriched proline]thyrotropin releasing factor: 13C-13C vicinal coupling constants and conformation of the proline residue.
Haar W; Fermandjian S; Vicar J; Blaha K; Fromageot P
Proc Natl Acad Sci U S A; 1975 Dec; 72(12):4948-52. PubMed ID: 813218
[TBL] [Abstract][Full Text] [Related]
7. s-Cis and s-trans isomerism of the His-Pro peptide bond in angiotensin and thyroliberin analogues.
Liakopoulou-Kyriakides M; Galardy RE
Biochemistry; 1979 May; 18(10):1952-7. PubMed ID: 35219
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and conformational studies by 1H- and 13C-NMR spectroscopy of a novel, sterically constrained analogue of thyrotropin-releasing hormone.
Mapelli C; Van Halbeek H; Stammer CH
Biopolymers; 1990 Feb; 29(2):407-22. PubMed ID: 2158826
[TBL] [Abstract][Full Text] [Related]
9. Conformational mobility of the pyrrolidine ring of proline in peptides and peptide hormones as manifest in carbon 13 spin-lattice relaxation times.
Deslauriers R; Smith IC; Walter R
J Biol Chem; 1974 Nov; 249(21):7006-10. PubMed ID: 4371430
[No Abstract] [Full Text] [Related]
10. Thyrotropin-releasing hormone: biosynthesis by rat hypothalamic fragments in vitro.
Mitnick M; Reichlin S
Science; 1971 Jun; 172(3989):1241-3. PubMed ID: 4995924
[TBL] [Abstract][Full Text] [Related]
11. Structure and synthesis of the thyrotropin-releasing hormone.
Enzmann F; Boler J; Folkers K; Bowers CY; Schally AV
J Med Chem; 1971 Jun; 14(6):469-74. PubMed ID: 4997119
[No Abstract] [Full Text] [Related]
12. Conformational analysis of thyrotropin releasing factor by proton magnetic resonance spectroscopy.
Montagut M; Lemanceau B; Bellocq AM
Biopolymers; 1974 Dec; 13(12):2615-29. PubMed ID: 4216374
[No Abstract] [Full Text] [Related]
13. Synthesis of analogs of the thyrotropin-releasing hormone and structure-activity relationship.
Chang JK; Sievertsson H; Currie B; Folkers K; Bowers C
J Med Chem; 1971 Jun; 14(6):484-7. PubMed ID: 4997122
[No Abstract] [Full Text] [Related]
14. Quantitative evaluation of gamma-turn conformation in proline-containing peptides using 13C N.M.R.
London RE
Int J Pept Protein Res; 1979; 14(5):377-87. PubMed ID: 119712
[TBL] [Abstract][Full Text] [Related]
15. Nuclear magnetic resonance studies of thyrotropin-releasing hormone (TRH) and analogues incorporating D-histidine and 4-hydroxy-L-proline.
Aksnes DW; Athanassopoulos C; Magafa V; Aaberg A; Francis GW; Papaioannou D
Acta Chem Scand (Cph); 1996 May; 50(5):411-6. PubMed ID: 8634183
[TBL] [Abstract][Full Text] [Related]
16. Synthetic thyrotropin-releasing factor analogs. 3. Effect of replacement or modification of histidine residue on biological activity.
Rivier J; Vale W; Monahan M; Ling N; Burgus R
J Med Chem; 1972 May; 15(5):479-82. PubMed ID: 4624684
[No Abstract] [Full Text] [Related]
17. Carbon-13 nuclear magnetic resonance investigations of hormone structure and function.
Smith IC; Deslauriers R
Recent Prog Horm Res; 1976; 33():309-32. PubMed ID: 801193
[No Abstract] [Full Text] [Related]
18. Determination of the tautomeric form of the imidazole ring of L-histidine in basic solution by carbon-13 magnetic resonance spectroscopy.
Reynolds WF; Peat IR; Freedman MH; Lyerla JR
J Am Chem Soc; 1973 Jan; 95(2):328-31. PubMed ID: 4687673
[No Abstract] [Full Text] [Related]
19. Hydrogen-1 and carbon-13 nuclear magnetic resonance conformational studies of the His-Pro peptide bond: conformational behavior of TRH.
Unkefer CJ; Walker RD; London RE
Int J Pept Protein Res; 1983 Nov; 22(5):582-9. PubMed ID: 6418675
[TBL] [Abstract][Full Text] [Related]
20. Conformational studies on the hypothalamic thyrotropin releasing factor and related compounds by 1-H nuclear magnetic resonance spectroscopy.
Donzel B; Rivier J; Goodman M
Biopolymers; 1974 Dec; 13(12):2631-47. PubMed ID: 4216375
[No Abstract] [Full Text] [Related]
[Next] [New Search]
